Waldron Private Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-852
Closed -$314K 341
2024
Q4
$314K Sell
852
-291
-25% -$122K 0.01% 324
2024
Q3
$594K Buy
1,143
+77
+7% +$41.1K 0.02% 229
2024
Q2
$578K Buy
1,066
+63
+6% +$33.3K 0.03% 210
2024
Q1
$520K Sell
1,003
-37
-4% -$18.4K 0.02% 235
2023
Q4
$490K Sell
1,040
-60
-5% -$27.7K 0.02% 236
2023
Q3
$479K Sell
1,100
-401
-27% -$182K 0.02% 238
2023
Q2
$667K Buy
1,501
+514
+52% +$237K 0.03% 197
2023
Q1
$454K Sell
987
-20
-2% -$9.52K 0.02% 267
2022
Q4
$457K Hold
1,007
0.03% 247
2022
Q3
$457K Buy
1,007
+25
+3% +$12K 0.03% 247
2022
Q2
$473K Buy
982
+11
+1% +$5.44K 0.03% 250
2022
Q1
$476K Buy
971
+244
+34% +$112K 0.02% 259
2021
Q4
$336K Buy
727
+2
+0.3% +$841 0.02% 296
2021
Q3
$270K Hold
725
0.02% 301
2021
Q2
$276K Sell
725
-15
-2% -$5.73K 0.02% 287
2021
Q1
$265K Sell
740
-41
-5% -$13.2K 0.02% 255
2020
Q4
$250K Buy
781
+32
+4% +$9.82K 0.02% 256
2020
Q3
$201K Buy
+749
New +$202K 0.02% 259
2019
Q2
Sell
-842
Closed -$241K 251
2019
Q1
$241K Buy
842
+51
+6% +$14.8K 0.03% 220
2018
Q4
$207K Buy
+791
New +$218K 0.03% 199

Other funds holding ELV

Waldron Private Wealth's ELV Position: Q1 2025 in Review

Waldron Private Wealth sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 852 shares — an estimated $314K sold.

Waldron Private Wealth first reported a position in ELV in Q4 2018 and held it in 20 quarters. The position peaked at $667K in Q2 2023. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Waldron Private Wealth reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Waldron Private Wealth sold 852 Elevance Health shares in Q1 2025, an estimated $314K.
  • Waldron Private Wealth first reported a position in Elevance Health in Q4 2018 and held it in 20 quarters.
  • Waldron Private Wealth's Elevance Health position peaked at $667K in Q2 2023.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Waldron Private Wealth's 13F filing for Q1 2025, filed 8 May 2025.